AKT1 and cancer: In cell assays, irisin showed its potential to inhibit epithelial-mesenchymal transition and cancer cell invasion via PI3K/Akt pathway, enhance the activity of caspase-3 and caspase-7 to induce cancer cell apoptosis, and inhibit the activity of NF-κb to reduce inflammation (40, 41).